Literature DB >> 18410556

Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index.

P-E Chang1, H-F Lui, Y-P Chau, K-H Lim, W-M Yap, C-K Tan, W-C Chow.   

Abstract

BACKGROUND: Transient elastography (TE) is a reliable non-invasive predictor of hepatic fibrosis, but data on TE in Asians are limited. AIM: To evaluate prospectively the accuracy of TE for diagnosis of hepatic fibrosis in Asians compared with APRI (aspartate transaminase to platelet ratio index).
METHODS: One hundred and twenty consecutive patients who underwent liver biopsy were enrolled. TE (Fibroscan) was performed by two independent operators. Fibrosis was graded by two independent pathologists using the METAVIR classification. Area under receiver operating curves (AUROC) were used to evaluate the accuracy of TE and APRI in diagnosing significant fibrosis (F >or= 2) and cirrhosis (F4).
RESULTS: Predominant aetiologies were hepatitis B (48%), non-alcoholic steatohepatitis (14%) and hepatitis C (8%). TE was unsuccessful in five patients (4.2%) because of small inter-costal space (three patients), obesity and ascites. There was good correlation between TE and fibrosis (r = 0.606). AUROC for diagnosis of significant fibrosis was 0.856 (95% CI 0.779-0.932) for TE and 0.673 (95% CI 0.568-0.777) for APRI. AUROC for diagnosis of cirrhosis was 0.924 (95% CI 0.857-0.990) for TE and 0.626 (95% CI 0.437-0.815) for APRI. Optimal TE value was 9.0 kPa for diagnosis of significant fibrosis and 16.0 kPa for cirrhosis with specificity/sensitivity/PPV/NPV/accuracy of 82.6%/85.2%/80.9%/86.7%/84.1% and 88.9%/82.7%/32.0%/98.8%/83.2%, respectively.
CONCLUSIONS: Transient elastography is a reliable predictor of hepatic fibrosis in Asians. Failure of TE in Asians is commonly because of small inter-costal space. TE is superior to APRI for non-invasive diagnosis of hepatic fibrosis and cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410556     DOI: 10.1111/j.1365-2036.2008.03711.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  24 in total

1.  FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.

Authors:  Keyur Patel; Mireen Friedrich-Rust; Yoav Lurie; Mircea Grigorescu; Carol Stanciu; Chuan-Mo Lee; Eugene R Schiff; Dieter Häussinger; Michael P Manns; Guido Gerken; Isabelle Colle; Michael Torbenson; Erik Pulkstenis; G Mani Subramanian; John G McHutchison; Stefan Zeuzem
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.

Authors:  Vincent Wai-Sun Wong; Pietro Lampertico; Victor de Lédinghen; Pik Eu Chang; Seung Up Kim; Yongpeng Chen; Henry Lik-Yuen Chan; Giampaolo Mangia; Juliette Foucher; Wan Cheng Chow; Sang Hoon Ahn; Jinlin Hou
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

Review 4.  Acoustic radiation force elasticity imaging in diagnostic ultrasound.

Authors:  Joshua R Doherty; Gregg E Trahey; Kathryn R Nightingale; Mark L Palmeri
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2013-04       Impact factor: 2.725

5.  Feasibility study and control values of transient elastography in healthy children.

Authors:  Guido Engelmann; Caroline Gebhardt; Daniel Wenning; Elke Wühl; Georg F Hoffmann; Buket Selmi; Juergen Grulich-Henn; Jens Peter Schenk; Ulrike Teufel
Journal:  Eur J Pediatr       Date:  2011-08-23       Impact factor: 3.183

6.  Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.

Authors:  Pik Eu Chang; Juanda Leo Hartono; Yee Lin Ngai; Yock Young Dan; Kieron Bl Lim; Wan Cheng Chow
Journal:  Singapore Med J       Date:  2018-12-17       Impact factor: 1.858

Review 7.  Can NASH be diagnosed, graded, and staged noninvasively?

Authors:  Garfield A Grandison; Paul Angulo
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

8.  External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients.

Authors:  Beom Kyung Kim; Kwang Hyub Han; Jun Yong Park; Sang Hoon Ahn; Chae Yoon Chon; Ja Kyung Kim; Yong Han Paik; Kwan Sik Lee; Young Nyun Park; Do Young Kim
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

9.  Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B.

Authors:  James Fung; Ching-Lung Lai; David But; Axel Hsu; Wai-Kay Seto; Charles Cheng; Danny Ka-Ho Wong; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2010-07-24       Impact factor: 6.047

10.  Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.

Authors:  Sang Hoon Ahn; Henry L Y Chan; Pei-Jer Chen; Jun Cheng; Mahesh K Goenka; Jinlin Hou; Seng Gee Lim; Masao Omata; Teerha Piratvisuth; Qing Xie; Hyung Joon Yim; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2010-02-20       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.